159 related articles for article (PubMed ID: 33880358)
1. Bioinformatics and
Hermawan A; Ikawati M; Khumaira A; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
Adv Pharm Bull; 2021 Feb; 11(2):351-360. PubMed ID: 33880358
[No Abstract] [Full Text] [Related]
2. Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and
Hermawan A; Ikawati M; Jenie RI; Khumaira A; Putri H; Nurhayati IP; Angraini SM; Muflikhasari HA
Saudi Pharm J; 2021 Jan; 29(1):12-26. PubMed ID: 33603536
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis.
Hermawan A; Khumaira A; Ikawati M; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
Comput Biol Chem; 2021 Feb; 90():107427. PubMed ID: 33360419
[TBL] [Abstract][Full Text] [Related]
4. Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and
Hermawan A; Ikawati M; Putri DDP; Fatimah N; Prasetio HH
Nutr Cancer; 2024 May; ():1-18. PubMed ID: 38721626
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
6. A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
Front Pharmacol; 2023; 14():1150774. PubMed ID: 36909163
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
8. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
9. Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells.
Xu C; Sun X; Qin S; Wang H; Zheng Z; Xu S; Luo G; Liu P; Liu J; Du N; Zhang Y; Liu D; Ren H
Cell Cycle; 2015; 14(11):1686-97. PubMed ID: 25955298
[TBL] [Abstract][Full Text] [Related]
10. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.
Hermawan A; Putri H; Utomo RY
Mol Divers; 2020 Nov; 24(4):933-947. PubMed ID: 31659695
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.
Wang R; Lv Q; Meng W; Tan Q; Zhang S; Mo X; Yang X
J Thorac Dis; 2014 Jun; 6(6):829-37. PubMed ID: 24977009
[TBL] [Abstract][Full Text] [Related]
13. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells.
Hermawan A; Putri H; Fatimah N; Prasetio HH
Heliyon; 2024 Jan; 10(2):e24356. PubMed ID: 38304813
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
Wu CH; Hong BH; Ho CT; Yen GC
J Agric Food Chem; 2015 Mar; 63(9):2432-41. PubMed ID: 25686711
[TBL] [Abstract][Full Text] [Related]
17. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
[TBL] [Abstract][Full Text] [Related]
18. Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.
Nguyen ST; Nguyen HL; Pham VQ; Nguyen GT; Tran CD; Phan NK; Pham PV
Onco Targets Ther; 2015; 8():323-34. PubMed ID: 25674007
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
20. Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.
Phan NL; Trinh NV; Pham PV
Onco Targets Ther; 2016; 9():49-59. PubMed ID: 26730203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
